For example, our analyses found little evidence to support causal roles of several metabolic traits (e.g. circulating HDL cholesterol, triglycerides, adiponectin, leptin) and inflammatory markers (CRP, IL-6) in endometrial cancer risk, despite these traits being linked to endometrial cancer risk in conventional observational analyses [18–22]. Here, ADIPOQ is linked to endometrial cancer.